Publications by authors named "V Accardo"

Background: Functional recovery remains a core clinical objective for patients with bipolar disorder (BD). Sociodemographic, clinical, and neurocognitive variables are associated with long-term functional impairment, yet the impact of sex differences is unclear. Functional remediation (FR) is a validated intervention aimed at achieving functional recovery in BD.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of stopping TNF inhibitors (TNFi) in children with juvenile idiopathic arthritis (JIA) who show persistent disease inactivity and identifies factors related to relapse.
  • A multicentric analysis of medical records from 136 JIA patients who discontinued TNFi treatment revealed that 79.4% experienced a relapse within a median of 5 months after stopping therapy.
  • Key predictors for relapse include younger age at onset, presence of uveitis, duration of treatment tapering, and not having persistent oligoarticular JIA.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the clinical features and treatment outcomes of three patients with juvenile idiopathic arthritis (JIA) and inborn errors of immunity (IEI) treated with biological DMARDs.
  • It highlights the cases of three young patients, two with 22q11.2 deletion syndrome and one with X-linked agammaglobulinemia, who had previously unresponsive JIA but achieved remission with specific biological therapies (etanercept, Adalimumab, and sirolimus plus abatacept).
  • The findings indicate that biological therapies can effectively manage disease activity in patients with these conditions without any observed adverse drug reactions.
View Article and Find Full Text PDF

Background: Neurocognitive impairment is a prominent characteristic of bipolar disorder (BD), linked with poor psychosocial functioning. This study's purpose is to evaluate the effectiveness of functional remediation (FR) in enhancing neurocognitive dysfunctions in a sample of remitted patients with diagnosis of BD in comparison to treatment as usual-TAU. To quantify the neurocognitive damage, the Brief Assessment of Cognition in Affective Disorders (BAC-A) will be used, and the overall psychosocial functioning will be measured with the Functioning Assessment Short Test-FAST.

View Article and Find Full Text PDF

Autism Spectrum Disorders (ASD) symptoms and internalized stigma (or self-stigma) can have a negative impact on cognitive and functional outcomes in people living with schizophrenia. Aim of the present study were to assess and compare internalized stigma, subjective well-being and other socio-demographic, clinical and functional characteristics in people diagnosed with schizophrenia with and without prominent autistic features. Ninety-four inpatients were assessed with measures of internalized stigma, subjective well-being, global clinical severity, schizophrenia symptoms severity, real-world functioning, medication side effects and attitude toward prescribed medications.

View Article and Find Full Text PDF